Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Videos

Is AstraZeneca Plc A Good Way To Play Emerging Markets?

| Owain Bennallack

VIDEO: One Fool weighs up the emerging-market potential of AstraZeneca plc (LON:AZN).

Read more »

Company Comment

Betting On AstraZeneca plc’s Drug Pipeline

| Owain Bennallack

What’s caused £41 billion drugs maker AstraZeneca plc (LON:AZN) to become afflicted by a seemingly interminable wasting disease?

Read more »

Investing Videos

A Closer Look At AstraZeneca plc

| Jill Ralph

VIDEO: Two Fools analyse AstraZeneca plc (LON: AZN).

Read more »

Company Comment

Earnings Drop 16% At AstraZeneca Plc

| Nate Weisshaar

Investing the future while revenues fall takes its toll on the bottom line at AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

Why You Might Think Of Investing In This FTSE Underdog: AstraZeneca plc

| Tony Reading

AstraZeneca plc (LON: AZN) could be a contrarian investment opportunity.

Read more »

Investing Articles

Why Reinvesting Your Dividends Is The Best Decision You’ll Ever Make

| Rupert Hargreaves

Dividend reinvestment is a great way to achieve market beating returns without much effort.

Read more »

Company Comment

2 Big Problems For GlaxoSmithKline Plc

| Leo Sun

It's been a rough year for pharmaceutical giant GlaxoSmithKline plc (LON: GSK).

Read more »

Investing Articles

4 Ways AstraZeneca plc Will Continue To Lead The Biotechnology Sector

| Rupert Hargreaves

How does AstraZeneca plc (LON: AZN) compare to its sector peers?

Read more »

Investing Articles

Why I Hate AstraZeneca plc

| Harvey Jones

Aside from its 5.6% yield, Harvey Jones finds little to love about AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

4 Ways GlaxoSmithKline plc Will Continue To Lag The Biotechnology Sector

| Rupert Hargreaves

How does GlaxoSmithKline plc (LON: GSK) compare to its sector peers?

Read more »

Investing Articles

21 Worrying Reasons Which Make AstraZeneca plc A Sell

| Royston Wild

Royston Wild reveals why shares in AstraZeneca plc (LON: AZN) are ready to shuttle lower.

Read more »

Investing Articles

News Flow Makes Me Want To Buy AstraZeneca plc

| Peter Stephens

I’m thinking of buying AstraZeneca plc (LON: AZN) and here’s why…

Read more »